Doogan Declan — SEC insider filings

SEC reporting owner CIK 1704234. 13 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2021-05-07 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Director5—13 legs · 154,524 sh · $13,319,59215
TENAX THERAPEUTICS, INC. (TENX)Director81 leg · 53,000 sh · $101,760—10

Insider filings — Doogan Declan

FiledFormIssuerReported transactionsSource
2026-09-174TENAX THERAPEUTICS, INC. (TENX)Purchase (P): 53,000 @ $1.92EDGAR
2026-01-134TENAX THERAPEUTICS, INC. (TENX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-07-034TENAX THERAPEUTICS, INC. (TENX)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2024-12-124TENAX THERAPEUTICS, INC. (TENX)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-08-124TENAX THERAPEUTICS, INC. (TENX)Gift (G): 567,871 @ $0 · Gift (G): 567,871 @ $0EDGAR
2022-06-104TENAX THERAPEUTICS, INC. (TENX)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2022-02-114/ABiohaven Pharmaceutical Holding Co Ltd. (BHVN)Sale (S): 11,706 @ $64.42 · Sale (S): 13,333 @ $64.71 · Sale (S): 12,580 @ $65.55 · Sale (S): 13,334 @ $66.01EDGAR
2022-02-114/ABiohaven Pharmaceutical Holding Co Ltd. (BHVN)Sale (S): 2,464 @ $67.83 · Sale (S): 13,334 @ $68.15 · Sale (S): 15,508 @ $68.58 · Sale (S): 10,000 @ $68.97EDGAR
2021-12-014Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Sale (S): 13,026 @ $112.40 · Sale (S): 11,499 @ $113.25EDGAR
2021-11-174Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 250,000 @ $0.61 · Option exercise (M): 175,000 @ $5.60 · Option exercise (M): 50,000 @ $9.29 · Option exercise (M): 18,000 @ $28.76 · Option exercise (M): 18,000 @ $61.76 · Option exercise (M): 30,000 @ $10.82 · +11 moreEDGAR
2021-08-114TENAX THERAPEUTICS, INC. (TENX)Gift (G): 567,871 @ $0EDGAR
2021-06-154TENAX THERAPEUTICS, INC. (TENX)Option exercise (M): 3,070,000 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 3,070 (derivative)EDGAR
2021-05-074Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 11,996 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1704234 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs